SCHEMBL19485901

SCHEMBL19485901

CCC(=O)C(CCC(F)(F)F)N(C)C(=O)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12966158 0.83 CTRB1 (0.31) —
SCHEMBL30916078 0.72 AAK1 (0.36) —
SCHEMBL30916093 0.67 AAK1 (0.33) —
SCHEMBL12966169 0.67 HDAC7 (0.36) —
SCHEMBL30476795 0.67 CHRM1 (0.45) —
SCHEMBL19485900 0.67 GAA (0.35) —
SCHEMBL20165468 0.66 USP2 (0.31) —
SCHEMBL25687091 0.66 MEN1 (0.33) —
SCHEMBL24298082 0.65 AAK1 (0.35) —
SCHEMBL30916082 0.65 AAK1 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9796705-B2 Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases MERCK SHARP & DOHME CORP. (US) 2017-10-24 — — US disclosed
Send feedback